Clinical Trials · NCT06863363

PEG-rhGH and Semaglutide Combination Therapy in Non-Diabetic Obese Adults

Not Yet RecruitingPhase 4Semaglutide (Investigational)
Phase
Phase 4
Recruitment status
Not Yet Recruiting
Sponsor
Shanghai Zhongshan Hospital
Enrollment
212
Start date
Not specified
Locations
1 site, China
Primary endpoint
The change in lean body weight (kg) from baseline
View Semaglutide compound reference